Acumen Pharmaceuticals In... (ABOS)
undefined
undefined%
At close: undefined
2.03
0.00%
After-hours Dec 13, 2024, 04:00 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19
Cash & Equivalents 66.89M 130.10M 122.16M 43.78M 6.55M
Short-Term Investments 176.64M 47.50M 72.08M - -
Long-Term Investments 62.55M 15.84M 31.62M - -
Other Long-Term Assets 454.00K 151.00K 14.00K - 144.00K
Receivables 225.00K - - 109.00K 30.00K
Inventory - - - - -
Other Current Assets 2.87M 2.72M 4.42M 543.00K 1.14M
Total Current Assets 246.62M 180.33M 198.66M 44.43M 7.18M
Property-Plant & Equipment 503.00K 270.00K 36.00K - -
Goodwill & Intangibles - - - - -
Total Long-Term Assets 63.51M 16.26M 31.67M - 144.00K
Total Assets 310.13M 196.59M 230.33M 44.43M 7.32M
Account Payables 1.38M 1.64M 1.09M 531.00K 223.00K
Deferred Revenue - - - - -
Short-Term Debt 1.73M 210.00K - - -
Other Current Liabilities 9.86M 5.96M 4.06M 5.84M 1.12M
Total Current Liabilities 12.97M 7.81M 5.15M 6.37M 1.34M
Long-Term Debt 27.62M - - - -
Other Long-Term Liabilities 2.56M - - 56.65M 17.40M
Total Long-Term Liabilities 30.18M - - 56.65M 17.40M
Total Liabilities 43.15M 7.81M 5.15M 63.02M 18.74M
Total Debt 28.49M 105.00K - - -
Common Stock 6.00K 4.00K 4.00K - -
Retained Earnings -222.80M -170.43M -127.57M -26.96M -19.64M
Comprehensive Income 312.00K -751.00K -231.00K - -
Shareholders Equity 266.97M 188.78M 225.18M -18.59M -11.42M
Total Investments 239.19M 63.34M 103.69M - -